First in Class Myeloma Pill Wins Accelerated FDA Approval for Patients at First Relapse or Later

FDA granted accelerated approval to iberdomide with daratumumab and dexamethasone for relapsed myeloma, the first CELMoD cleared for the disease.

Have A Referral?